HIMS & HERS HEALTH INC (HIMS) Fundamental Analysis & Valuation

NYSE:HIMS • US4330001060

Current stock price

20.77 USD
+1.99 (+10.6%)
At close:
20.76 USD
-0.01 (-0.05%)
After Hours:

This HIMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HIMS Profitability Analysis

1.1 Basic Checks

  • HIMS had positive earnings in the past year.
  • In the past year HIMS had a positive cash flow from operations.
  • In multiple years HIMS reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • The Return On Assets of HIMS (5.96%) is better than 79.00% of its industry peers.
  • HIMS has a Return On Equity of 23.73%. This is amongst the best in the industry. HIMS outperforms 91.00% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.49%, HIMS is in line with its industry, outperforming 59.00% of the companies in the same industry.
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROIC 5.49%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • The Profit Margin of HIMS (5.47%) is better than 79.00% of its industry peers.
  • HIMS's Operating Margin of 5.18% is fine compared to the rest of the industry. HIMS outperforms 62.00% of its industry peers.
  • The Gross Margin of HIMS (73.83%) is better than 89.00% of its industry peers.
  • In the last couple of years the Gross Margin of HIMS has declined.
Industry RankSector Rank
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. HIMS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
  • Compared to 1 year ago, HIMS has more shares outstanding
  • The number of shares outstanding for HIMS has been increased compared to 5 years ago.
  • Compared to 1 year ago, HIMS has a worse debt to assets ratio.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • HIMS has an Altman-Z score of 3.00. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of HIMS (3.00) is better than 67.00% of its industry peers.
  • The Debt to FCF ratio of HIMS is 16.94, which is on the high side as it means it would take HIMS, 16.94 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of HIMS (16.94) is worse than 63.00% of its industry peers.
  • A Debt/Equity ratio of 1.80 is on the high side and indicates that HIMS has dependencies on debt financing.
  • The Debt to Equity ratio of HIMS (1.80) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Altman-Z 3
ROIC/WACC0.64
WACC8.56%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.90 indicates that HIMS should not have too much problems paying its short term obligations.
  • HIMS has a better Current ratio (1.90) than 80.00% of its industry peers.
  • HIMS has a Quick Ratio of 1.70. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.70, HIMS is in the better half of the industry, outperforming 73.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.7
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. HIMS Growth Analysis

3.1 Past

  • The earnings per share for HIMS have decreased by -5.56% in the last year.
  • The Revenue has grown by 59.00% in the past year. This is a very strong growth!
  • Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 64.55% on average per year.
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%

3.2 Future

  • Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 50.73% on average per year.
  • The Revenue is expected to grow by 14.53% on average over the next years. This is quite good.
EPS Next Y7.08%
EPS Next 2Y17.86%
EPS Next 3Y29.51%
EPS Next 5Y50.73%
Revenue Next Year17.57%
Revenue Next 2Y18.47%
Revenue Next 3Y17.87%
Revenue Next 5Y14.53%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. HIMS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 40.73, HIMS can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
  • HIMS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.75.
  • With a Price/Forward Earnings ratio of 38.03, HIMS can be considered very expensive at the moment.
  • HIMS's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of HIMS to the average of the S&P500 Index (22.10), we can say HIMS is valued expensively.
Industry RankSector Rank
PE 40.73
Fwd PE 38.03
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS is on the same level as its industry peers.
  • HIMS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. HIMS is more expensive than 62.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 82.46
EV/EBITDA 24.56
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
  • HIMS's earnings are expected to grow with 29.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.75
PEG (5Y)N/A
EPS Next 2Y17.86%
EPS Next 3Y29.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIMS Dividend Analysis

5.1 Amount

  • No dividends for HIMS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIMS Fundamentals: All Metrics, Ratios and Statistics

HIMS & HERS HEALTH INC

NYSE:HIMS (3/31/2026, 4:01:07 PM)

After market: 20.76 -0.01 (-0.05%)

20.77

+1.99 (+10.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners85.66%
Inst Owner Change-9.76%
Ins Owners6.6%
Ins Owner Change21.93%
Market Cap4.73B
Revenue(TTM)2.35B
Net Income(TTM)128.37M
Analysts54.29
Price Target25.63 (23.4%)
Short Float %40.55%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.8%
Min EPS beat(2)-43.53%
Max EPS beat(2)71.14%
EPS beat(4)3
Avg EPS beat(4)25.02%
Min EPS beat(4)-43.53%
Max EPS beat(4)71.14%
EPS beat(8)7
Avg EPS beat(8)139.72%
EPS beat(12)10
Avg EPS beat(12)110.2%
EPS beat(16)13
Avg EPS beat(16)84.74%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)1.2%
Revenue beat(4)2
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.24%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)12
Avg Revenue beat(16)2.47%
PT rev (1m)-14.58%
PT rev (3m)-44.76%
EPS NQ rev (1m)-77.8%
EPS NQ rev (3m)-79.18%
EPS NY rev (1m)-6.07%
EPS NY rev (3m)-8.87%
Revenue NQ rev (1m)-5.61%
Revenue NQ rev (3m)-5.81%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 40.73
Fwd PE 38.03
P/S 2.02
P/FCF 82.46
P/OCF 15.78
P/B 8.75
P/tB 71.21
EV/EBITDA 24.56
EPS(TTM)0.51
EY2.46%
EPS(NY)0.55
Fwd EY2.63%
FCF(TTM)0.25
FCFY1.21%
OCF(TTM)1.32
OCFY6.34%
SpS10.3
BVpS2.37
TBVpS0.29
PEG (NY)5.75
PEG (5Y)N/A
Graham Number5.22
Profitability
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROCE 6.95%
ROIC 5.49%
ROICexc 8.2%
ROICexgc 13.77%
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
FCFM 2.45%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
F-Score5
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Debt/EBITDA 5.52
Cap/Depr 445.11%
Cap/Sales 10.33%
Interest Coverage 250
Cash Conversion 170.27%
Profit Quality 44.73%
Current Ratio 1.9
Quick Ratio 1.7
Altman-Z 3
F-Score5
WACC8.56%
ROIC/WACC0.64
Cap/Depr(3y)344.08%
Cap/Depr(5y)250.41%
Cap/Sales(3y)5.65%
Cap/Sales(5y)4.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y7.08%
EPS Next 2Y17.86%
EPS Next 3Y29.51%
EPS Next 5Y50.73%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year17.57%
Revenue Next 2Y18.47%
Revenue Next 3Y17.87%
Revenue Next 5Y14.53%
EBIT growth 1Y78.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year197.78%
EBIT Next 3Y70.33%
EBIT Next 5Y47.66%
FCF growth 1Y-71.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.48%
OCF growth 3YN/A
OCF growth 5YN/A

HIMS & HERS HEALTH INC / HIMS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to HIMS.


What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a valuation rating of 1 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.


What is the profitability of HIMS stock?

HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 4 / 10.


What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?

The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.